Heart Test Laboratories Stock Performance
| HSCS Stock | USD 3.45 0.21 5.74% |
On a scale of 0 to 100, Heart Test holds a performance score of 3. The company retains a Market Volatility (i.e., Beta) of 0.56, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Heart Test's returns are expected to increase less than the market. However, during the bear market, the loss of holding Heart Test is expected to be smaller as well. Please check Heart Test's coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Heart Test's current trending patterns will revert.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Heart Test Laboratories are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating fundamental indicators, Heart Test unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 5.8 M | |
| Total Cashflows From Investing Activities | -30.2 K |
Heart Test Relative Risk vs. Return Landscape
If you would invest 324.00 in Heart Test Laboratories on October 27, 2025 and sell it today you would earn a total of 21.00 from holding Heart Test Laboratories or generate 6.48% return on investment over 90 days. Heart Test Laboratories is currently generating 0.2662% in daily expected returns and assumes 5.7825% risk (volatility on return distribution) over the 90 days horizon. In different words, 51% of stocks are less volatile than Heart, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Heart Test Target Price Odds to finish over Current Price
The tendency of Heart Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 3.45 | 90 days | 3.45 | nearly 4.98 |
Based on a normal probability distribution, the odds of Heart Test to move above the current price in 90 days from now is nearly 4.98 (This Heart Test Laboratories probability density function shows the probability of Heart Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Heart Test has a beta of 0.56. This usually indicates as returns on the market go up, Heart Test average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Heart Test Laboratories will be expected to be much smaller as well. Additionally Heart Test Laboratories has an alpha of 0.2178, implying that it can generate a 0.22 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Heart Test Price Density |
| Price |
Predictive Modules for Heart Test
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Heart Test Laboratories. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Heart Test's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Heart Test Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Heart Test is not an exception. The market had few large corrections towards the Heart Test's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Heart Test Laboratories, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Heart Test within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.22 | |
β | Beta against Dow Jones | 0.56 | |
σ | Overall volatility | 0.34 | |
Ir | Information ratio | 0.03 |
Heart Test Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Heart Test for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Heart Test Laboratories can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Heart Test had very high historical volatility over the last 90 days | |
| Heart Test has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 4.35 K. Net Loss for the year was (8.77 M) with profit before overhead, payroll, taxes, and interest of 5.02 K. | |
| Heart Test Laboratories currently holds about 4.27 M in cash with (7.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52. |
Heart Test Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Heart Stock often depends not only on the future outlook of the current and potential Heart Test's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Heart Test's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 938.3 K | |
| Cash And Short Term Investments | 1.1 M |
Heart Test Fundamentals Growth
Heart Stock prices reflect investors' perceptions of the future prospects and financial health of Heart Test, and Heart Test fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Heart Stock performance.
| Return On Equity | -2.2 | |||
| Return On Asset | -0.75 | |||
| Operating Margin | (857.13) % | |||
| Current Valuation | 9.89 M | |||
| Shares Outstanding | 3.18 M | |||
| Price To Book | 2.62 X | |||
| Price To Sales | 1,265 X | |||
| Revenue | 4.35 K | |||
| EBITDA | (8.14 M) | |||
| Cash And Equivalents | 4.27 M | |||
| Cash Per Share | 0.52 X | |||
| Total Debt | 2.99 M | |||
| Debt To Equity | 0.41 % | |||
| Book Value Per Share | 1.36 X | |||
| Cash Flow From Operations | (7.41 M) | |||
| Earnings Per Share | (6.56) X | |||
| Total Asset | 4.22 M | |||
| Retained Earnings | (76.13 M) | |||
About Heart Test Performance
Assessing Heart Test's fundamental ratios provides investors with valuable insights into Heart Test's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Heart Test is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company was incorporated in 2007 and is headquartered in Southlake, Texas. Heart Test operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.Things to note about Heart Test Laboratories performance evaluation
Checking the ongoing alerts about Heart Test for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Heart Test Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Heart Test had very high historical volatility over the last 90 days | |
| Heart Test has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 4.35 K. Net Loss for the year was (8.77 M) with profit before overhead, payroll, taxes, and interest of 5.02 K. | |
| Heart Test Laboratories currently holds about 4.27 M in cash with (7.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52. |
- Analyzing Heart Test's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Heart Test's stock is overvalued or undervalued compared to its peers.
- Examining Heart Test's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Heart Test's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Heart Test's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Heart Test's stock. These opinions can provide insight into Heart Test's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.